Increasing the Barriers for the Access to Affordable Medicines
- Opinión
Most free trade agreements signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization. The leaked text on intellectual property of the Trans-Pacific Partnership (TPP) currently under negotiation goes further than those FTAs. It reflects the ambition of such companies to obtain even higher levels of protection. This paper discusses some characteristics of the TTP negotiations and the main possible outcomes that may negatively affect access to medicines, notably in developing countries.
South Centre Research Paper 62, September 2015
Del mismo autor
- EU-MERCOSUR Trade Negotiations must not impose TRIPS Plus provisions on Protection and Enforcement of Intellectual Property Rights 04/12/2017
- China’s Debt Problem and Rising Systemic Risks 21/11/2017
- Policy brief: The Financial Crisis and the Global South: Impact and Prospects 02/08/2017
- Outcomes of the Nineteenth Session of the WIPO Committee on Development and Intellectual Property: A Critical Reflection 13/06/2017
- The Financial Crisis and the Global South: Impact and Prospects 11/05/2017
- Is the Right to Use Trademarks Mandated by the TRIPS Agreement? 16/11/2016
- The NAM Summit Declaration in summary 06/11/2016
- Corporations, Investment Decisions and Human Rights Regulatory Frameworks 21/10/2016
- South Centre statement to the WIPO Assemblies 2016 04/10/2016
- The South Centre Endorses the Report of the UN High Level Panel on Access to Medicines 20/09/2016
Crisis Económica
- Geraldina Colotti 07/04/2022
- Julio C. Gambina 07/04/2022
- Rafael Bautista S. 06/04/2022
- Julio Gambina 04/04/2022
- José Ramón Cabañas Rodríguez 01/04/2022
